LITTLE ROCK (KATV) — A new form of focal therapy for prostate cancer has made its way to the Natural State, set to be offered by the University of Arkansas for Medical Sciences. NanoKnife ...

AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer patients. The system, which was already FDA-cleared for the surgical ...

Focal therapy treats prostate cancers without surgery and its potential side effects. It follows a fundraising campaign which ...

As nano knife represents a meaningful advancement in prostate cancer treatment. In the quarter, we continue to be encouraged by trends in the adoption and utilization of NanoKnife, evidenced by ...

ARKANSAS, USA — UAMS announced Wednesday that it is the first provider in Arkansas to use NanoKnife technology, a new form of focal therapy for localized prostate cancer. Focal therapy is a ...

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) recently became the first provider in Arkansas of NanoKnife technology, a new form of focal therapy for localized prostate cancer.

Northeast Georgia Medical Center Braselton announced Monday it will be the first hospital in North Georgia to offer the NanoKnife System as a surgical option for prostate cancer patients. NGMC ...